Vimarsana
Biggest News Aggregation in the World

Software Precertification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Software Precertification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Software Precertification Today - Breaking & Trending Today

Generative AI For Mental Health Is Upping The Ante By Going Multi-Modal, Embracing E-Wearables, And A Whole Lot More - Vimarsana News

Generative AI For Mental Health Is Upping The Ante By Going Multi-Modal, Embracing E-Wearables, And A Whole Lot More

On my continuing coverage of generative AI used for mental health, I take a look at the latest trends and what is coming down the pike. Get ready for what will happen.

Source: forbes.com
The FDA Regulatory Landscape For AI In Medical Devices - Vimarsana News

The FDA Regulatory Landscape For AI In Medical Devices

This article reviews the existing FDA programs impacting artificial intelligence (AI) / machine learning (ML) technologies in medtech, as well as the...

Digital Health: Significant FDA Policy Developments In 2022 - Healthcare - Vimarsana News

Digital Health: Significant FDA Policy Developments In 2022 - Healthcare

In 2022, FDA retreated from a flexible approach to its regulation of digital health in two key areas: (1) its PreCertification Program for software as a medical device (SaMD) and (2) its guidance...

Source: mondaq.com
FDA's Latest Twist on Digital Health Oversight Brings Big Shift | Cooley LLP - Vimarsana News

FDA's Latest Twist on Digital Health Oversight Brings Big Shift | Cooley LLP

Facing novel, swiftly evolving technologies in the digital health space, the US Food and Drug Administration has been trying to balance fostering innovation with providing reasonable...

FDA Vs Congress The Software Showdown - Vimarsana News

FDA Vs Congress The Software Showdown

September 2022 will be remembered as a seminal turning point in digital health in the U.S. With the FDA’s final guidance on Clinical...